Regulation of activity of cathepsins B, L, and D in murine lymphosarcoma model at a combined treatment with cyclophosphamide and yeast polysaccharide

Cancer Letters

Volumn 223, Issue 1, 2005, Pages 77-83

  Khalikova, Tatyana A ^a   Zhanaeva, Svetlana Ya ^a   Korolenko, Tatyana A ^a   Kaledin, Vassilij I ^b   Kogan, Grigorij ^c  

^a INSTITUTE OF PHYSIOLOGY   (Russian Federation)

^b INSTITUTE OF CYTOLOGY AND GENETICS   (Russian Federation)

^c INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Cathepsins B, L, and D; Murine Lymphosarcoma; Yeast glucan

Indexed keywords

ASPARTIC PROTEINASE; CATHEPSIN B; CATHEPSIN D; CATHEPSIN L; CYCLOPHOSPHAMIDE; CYSTEINE PROTEINASE; POLYSACCHARIDE; SULFOETHYL GLUCAN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY MASS; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; DRUG POTENTIATION; ENZYME ACTIVITY; LIVER; LYMPHOSARCOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN;

ANIMALS; CATHEPSIN B; CATHEPSIN D; CATHEPSINS; CYCLOPHOSPHAMIDE; CYSTEINE ENDOPEPTIDASES; GLUCANS; LYMPHOMA, DIFFUSE; MALE; MICE; MICE, INBRED CBA; MICE, INBRED DBA; YEASTS;

MURINAE;

EID: 18844444201     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.10.028     Document Type: Article

References (23)

1. B. Turk, D. Turk, and G.S. Salvesen Regulating cysteine protease activity: essential role of protease inhibitors as guardians and regulators Curr. Pharm. Des. 8 2002 1623 1637
2. B. Werle, B. Jülke, T. Lah, J. Kos, E. Spiess, and W. Ebert Cathepsin B and cathepsin L: Prognostic factors in human lung cancer? V.K. Hopsu-Havu M. Järvinen H. Kirschke Proteolysis in Cell Functions 1997 IOS Press Amsterdam 472 478
3. J. Kos, B. Stabuc, A. Schweiger, M. Krasovec, N. Cimerman, N. Kopitar-Jerala, and I. Vrhovec Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients Clin. Cancer Res. 3 1997 1815 1822
4. T.A. Korolenko, S.Y. Zhanaeva, O.N. Poteryaeva, O.V. Falameeva, O.A. Levina, V.I. Kaledin, and I. Shandula Activity and concentration of cathepsin B as prognostic criteria for the development of mouse LS lymphosarcoma and Lewis lung adenocarcinoma Bull. Exp. Biol. Med. 133 2002 392 395
5. R. Castino, D. Pace, M. Demoz, M. Gargiulo, C. Ariatta, E. Raiteri, and C. Isidoro Lysosomal proteases as potential targets for the induction of apoptotic cell death in human neuroblastomas Int. J. Cancer 97 2002 775 779
6. M.E. Guicciardi, H. Miyoshi, S.F. Bronk, and G.J. Gores Cathepsin B knockout mice are resistant to tumor necrosis factor-α-mediated hepatocyte apoptosis and liver injure: implications for therapeutic applications Am. J. Pathol. 159 2001 2045 2054
7. K. Roberg, K. Kågedal, and K. Öllinger Microinjection of cathepsin D induced caspases-dependent apoptosis in fibroblasts Am. J. Pathol. 161 2002 89 96
8. N. Levicar, R.A. Dewey, E. Daley, T.E. Bates, D. Davies, J. Kos, G.J. Pikington, and T.T. Lah Selective suppression of cathepsin L by antisense cDNA impairs human brain tumor cell invasion in vitro and promotes apoptosis Cancer Gene Ther. 10 2003 141 151
9. V.I. Kaledin, V.P. Nikolin, T.A. Ageeva, O.A. Timofeeva, M.L. Filipenko, G.M. Ronichevskaia, T.S. Morozkova, N.A. Popova, and T.Iu Baimak Cyclophosphamide-induced apoptosis of murine lymphosarcoma cells in vivo Vopr. Onkol. 46 2000 588 593
10. A. Iu Grishanova, V.I. Kaledin, T.V. Zueva, E.K. Nekhoroshkova, V.P. Nikolin, and V.V. Liakhovich Activity and induction of CYP2B, CYP2C, and CYP3A in tissues of cyclophosphane-sensitive and resistant neoplasms and the liver of neoplasm-carrying mice Biomed. Khim. 49 2003 27 34
11. D. Chorvatovičová, Z. Kováčiková, J. Šandula, and J. Navarová Protective effect of sulfoethylglucan against hexavalent chromium Mutat. Res. 302 1993 207 211
12. G. Kogan, J. Šandula, T.A. Korolenko, O. Falameeva, O. Poteryaeva, S. Zhanaeva, O. Levina, T. Filatova, and V. Kaledin Increased efficiency of Lewis lung carcinoma chemotherapy with a macrophage stimulator - yeast carboxymethyl glucan Int. Immunopharmacol. 2 2002 775 781
13. D.L. Morton, and A. Bart Local therapy by biological agents V.T. DeVit Biological methods for therapy of oncological diseases [in Russian], Meditsina, Moscow 2002 710 724
14. J.S. Kleinerman, and I.J. Fiedler Macrophage stimulation by liposomes containing immunomodulators V.T. DeVit Biological Methods for Therapy of Oncological Diseases [in Russian], Meditsina, Moscow 2002 853 864
15. G. Kogan (1→3,1→6)-β-d-Glucans of yeasts and fungi and their biological activity Atta-ur-Rahman Studies in Natural Products Chemistry Bioactive Natural Products (Part D) vol. 23 2000 Elsevier Amsterdam 107 152
16. J.A. Bohn, and J.N. BeMiller (1→3)-β-d-Glucans as biological response modifiers: a review of structure-functional activity relationships Carbohydr. Polym. 28 1995 3 14
17. S. Kasai, S. Fujimoto, K. Nitta, H. Baba, and T. Kunimoto Antitumor activity of polymorphonuclear leukocytes activated by a beta-1,3-d-glucan J. Pharmacobiodyn. 14 1991 519 525
18. E.R. Sherwood, D.L. Williams, R.B. McNamee, E.L. Jones, I.W. Browder, and N.R. DiLuzio In vitro tumoricidal activity of resting and glucan-activated Kupffer cells J. Leukocyte Biol. 42 1987 69 75
19. D.L. Williams, E.R. Sherwood, R.B. McNamee, E.L. Jones, I.W. Browder, and N.R. DiLuzio Chemoimmunotherapy of experimental hepatic metastases Hepatology 7 1987 1296 1304
20. K. Tokunaka, N. Ohno, Y. Adachi, N. Miura, and T. Yadomae Application of Candida solubilized cell wall β-glucan in antitumor immunotherapy against P815 mastocytoma in mice Int. Immunopharmacol. 2 2002 59 67
21. O.V. Falameeva, O.N. Poteryaeva, S.Ya. Zhanaeva, O.A. Levina, T.G. Filatova, T.A. Korolenko, V.I. Kaledin, I. Sandula, and G. Kogan Macrophage stimulator β-(1→3)-d-carboxymethylglucan improves the efficiency of chemotherapy of Lewis lung carcinoma Bull. Exp. Biol. Med. 132 2001 787 790
22. T.A. Usova, O.N. Poteryaeva, S.Ya. Zhanaeva, E.S. Yarygina, and T.A. Korolenko Cystatin C and cysteine proteinases during the development and therapy of Lewis lung adenocarcinoma in mice Bull. Exp. Biol. Med. 135 2003 81 84
23. V. Kaledin, Y. Kurunov, and I. Serova Inhibition and stimulation of the growth of Krebs-2 carcinoma by BCG vaccine J. Natl Cancer Inst. 58 1977 1271 1277